Canaccord Bullish on Joby Aviation, Lilium, Vertical Aerospace, Eve, Archer Aviation: eVTOL Stocks
- June 09th, 2023
- 410 views
Joby Aviation, Inc. (NYSE: JOBY), a leading electric aviation company focused on the development of vertical takeoff and landing (VTOL) aircraft, has been initiated with a Buy rating and Price Target of $8 by Canaccord Genuity.
With $JOBY closing at $6.26 on Thursday, this suggests a potential upside of $1.74 or 27.78%, according to Canaccord Genuity's analysis.
Lilium N.V. (Nasdaq: LILM), a German aerospace company specializing in electric vertical takeoff and landing (eVTOL) aircraft, has received a Hold rating and Price Target of $1.2 from Canaccord Genuity.
With Thursday's closing price of $1.09, the brokerage firm's assessment implies a potential upside of $0.11 or 10.09% for $LILM.
Vertical Aerospace Ltd. (NYSE: EVTL), a British aircraft manufacturer focused on the development of electric vertical takeoff and landing aircraft, has been initiated with a Hold rating and Price Target of $2 by Canaccord Genuity.
Despite $EVTL closing at $1.88 on Thursday, the assigned price target suggests a potential upside of $0.12 or 6.38%, as per Canaccord Genuity's perspective.
Eve Holding, Inc. (NYSE: EVEX), a Brazilian aviation company specializing in electric vertical takeoff and landing aircraft, has been initiated with a Buy rating and Price Target of $10 by Canaccord Genuity.
With $EVEX closing at $8.00 on Thursday, this indicates a potential upside of $2.00 or 25% according to the brokerage firm's analysis.
Archer Aviation Inc. (NYSE: ACHR), an American aerospace company focused on the development of electric vertical takeoff and landing aircraft, has been initiated with a Buy rating and Price Target of $9 by Canaccord Genuity.
With Thursday's closing price of $3.06, this suggests a potential upside of $5.94 or 194.12% for $ACHR, as per Canaccord Genuity's view.
Please note that the potential upside figures are based on Canaccord Genuity's views and may not reflect the actual market performance. Investors should conduct their own research and consider other factors before making any investment decisions.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
December 05th, 2025
FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
December 04th, 2025December 02nd, 2025Earnings Countdown: Salesforce, Snowflake, and Guidewire Take Center Stage
November 30th, 2025Wall Street Eyes CrowdStrike, Marvell Technology, and GitLab as Earnings Near
November 30th, 2025




Member Login